Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Microsoft
MSFT
|
+$306M |
| 2 |
Alibaba
BABA
|
+$177M |
| 3 |
Verizon
VZ
|
+$128M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$128M |
| 5 |
McKesson
MCK
|
+$123M |
Top Sells
| 1 |
Amazon
AMZN
|
+$466M |
| 2 |
Gilead Sciences
GILD
|
+$319M |
| 3 |
Meta Platforms (Facebook)
META
|
+$218M |
| 4 |
Intel
INTC
|
+$215M |
| 5 |
Coca-Cola
KO
|
+$191M |
Sector Composition
| 1 | Healthcare | 13.5% |
| 2 | Technology | 12.64% |
| 3 | Industrials | 10.38% |
| 4 | Financials | 10.17% |
| 5 | Consumer Discretionary | 10.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
RC
2051
Ready Capital
RC
$698M
| $2.02M | ﹤0.01% |
124,849
-1,836
| -1% | -$29.7K |
|
|
HPJ
2052
DELISTED
Highpower International Inc
HPJ
| $2.01M | ﹤0.01% |
522,100
+22,800
| +5% | +$87.8K |
|
|
BCA
2053
DELISTED
CORPBANCA SPONSORED ADR REPSTG (1-1,500)COM STK
BCA
| $2.01M | ﹤0.01% |
121,664
-11,002
| -8% | -$182K |
|
|
BIND
2054
DELISTED
BIND THERAPEUTICS INC
BIND
| $2.01M | ﹤0.01% |
359,400
+251,032
| +232% | +$1.4M |
|
2055
Murphy Oil
MUR
$3.84B
| $2M | ﹤0.01% |
48,200
+13,500
| +39% | +$561K |
|
|
ECYT
2056
DELISTED
Endocyte, Inc. Common Stock
ECYT
| $2M | ﹤0.01% |
386,112
+7,012
| +2% | +$36.4K |
|
2057
Old Second Bancorp
OSBC
$943M
| $1.99M | ﹤0.01% |
302,008
+115,408
| +62% | +$762K |
|
2058
Big 5 Sporting Goods
BGFV
$30.9M
| $1.99M | ﹤0.01% |
140,000
+86,700
| +163% | +$1.23M |
|
2059
Bright Horizons
BFAM
$6.21B
| $1.99M | ﹤0.01% |
+34,400
| New | +$1.99M |
|
2060
RadNet
RDNT
$5.78B
| $1.99M | ﹤0.01% |
296,700
-25,100
| -8% | -$168K |
|
|
OKS
2061
DELISTED
Oneok Partners LP
OKS
| $1.98M | ﹤0.01% |
58,350
-162,979
| -74% | -$5.54M |
|
|
STFC
2062
DELISTED
State Auto Financial Corp
STFC
| $1.98M | ﹤0.01% |
82,799
+44,731
| +118% | +$1.07M |
|
2063
Coherent
COHR
$16.1B
| $1.98M | ﹤0.01% |
104,400
+86,900
| +497% | +$1.65M |
|
2064
Stellantis
STLA
$28B
| $1.98M | ﹤0.01% |
+207,151
| New | +$1.98M |
|
|
LTRPA
2065
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
| $1.98M | ﹤0.01% |
+61,400
| New | +$1.98M |
|
|
SRGA
2066
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $1.97M | ﹤0.01% |
10,181
+8,014
| +370% | +$1.55M |
|
2067
Wayfair
W
$11.2B
| $1.97M | ﹤0.01% |
+52,300
| New | +$1.97M |
|
2068
Lam Research
LRCX
$154B
| $1.97M | ﹤0.01% |
+241,560
| New | +$1.97M |
|
2069
Twin Disc
TWIN
$191M
| $1.96M | ﹤0.01% |
105,166
+38,066
| +57% | +$709K |
|
2070
Constellium
CSTM
$2.13B
| $1.96M | ﹤0.01% |
+165,500
| New | +$1.96M |
|
2071
German American Bancorp
GABC
$1.52B
| $1.96M | ﹤0.01% |
99,753
+46,503
| +87% | +$913K |
|
|
LAYN
2072
DELISTED
Layne Christensen Co
LAYN
| $1.96M | ﹤0.01% |
218,654
+125,285
| +134% | +$1.12M |
|
2073
Cato Corp
CATO
$91.5M
| $1.96M | ﹤0.01% |
50,450
+22,900
| +83% | +$887K |
|
2074
Hyster-Yale Materials Handling
HY
$639M
| $1.95M | ﹤0.01% |
28,200
-10,600
| -27% | -$734K |
|
2075
Supernus Pharmaceuticals
SUPN
$2.51B
| $1.95M | ﹤0.01% |
+115,000
| New | +$1.95M |
|